首页 > 最新文献

Clinica e Investigacion en Ginecologia y Obstetricia最新文献

英文 中文
Uso de plasma rico en plaquetas en el campo de la reproducción humana asistida 在人类辅助生殖领域使用富血小板血浆
IF 0.1 Q4 OBSTETRICS & GYNECOLOGY Pub Date : 2025-01-01 Epub Date: 2024-11-27 DOI: 10.1016/j.gine.2024.101016
P. Luque González , M. Pineda Mateo , J. Rodríguez Sánchez-Reyman
Assisted reproductive therapies have a limited success rate. New therapies are currently being investigated to increase their effectiveness, such as the use of platelet-rich plasma (PRP). This agent has demonstrated efficacy at the level of regenerative medicine and consists of the administration of blood plasma extracted from the patient herself with a high platelet count. Given the recent incorporation of this treatment in clinical research, the objective is to carry out a bibliographic review to elucidate the characteristics of its use, effects and benefits. The literature available in the main databases offers very optimistic results. It has been shown that PRP favors endometrial regeneration and folliculogenesis as well as restoration of the menstrual cycle, which may be useful in patients with thin endometrium refractory to classical treatments, chronic endometritis, repeated implantation failure, early ovarian failure or Asherman's syndrome. However, there are few studies and they have a small sample size, so it is necessary to continue and expand the research on PRP.
辅助生殖疗法的成功率有限。目前正在研究新的疗法,以提高其有效性,如使用富血小板血浆(PRP)。这种药物已在再生医学层面上证明了其疗效,其原理是从患者自身提取的高血小板血浆。鉴于这种疗法最近已被纳入临床研究,我们的目的是进行文献综述,以阐明其使用特点、效果和益处。主要数据库中的文献提供了非常乐观的结果。研究表明,PRP 有利于子宫内膜再生和卵泡生成,以及月经周期的恢复,这可能对传统治疗方法难治的子宫内膜薄、慢性子宫内膜炎、反复种植失败、早期卵巢功能衰竭或阿舍曼综合征患者有用。然而,相关研究较少,样本量也较小,因此有必要继续扩大对 PRP 的研究。
{"title":"Uso de plasma rico en plaquetas en el campo de la reproducción humana asistida","authors":"P. Luque González ,&nbsp;M. Pineda Mateo ,&nbsp;J. Rodríguez Sánchez-Reyman","doi":"10.1016/j.gine.2024.101016","DOIUrl":"10.1016/j.gine.2024.101016","url":null,"abstract":"<div><div>Assisted reproductive therapies have a limited success rate. New therapies are currently being investigated to increase their effectiveness, such as the use of platelet-rich plasma (PRP). This agent has demonstrated efficacy at the level of regenerative medicine and consists of the administration of blood plasma extracted from the patient herself with a high platelet count. Given the recent incorporation of this treatment in clinical research, the objective is to carry out a bibliographic review to elucidate the characteristics of its use, effects and benefits. The literature available in the main databases offers very optimistic results. It has been shown that PRP favors endometrial regeneration and folliculogenesis as well as restoration of the menstrual cycle, which may be useful in patients with thin endometrium refractory to classical treatments, chronic endometritis, repeated implantation failure, early ovarian failure or Asherman's syndrome. However, there are few studies and they have a small sample size, so it is necessary to continue and expand the research on PRP.</div></div>","PeriodicalId":41294,"journal":{"name":"Clinica e Investigacion en Ginecologia y Obstetricia","volume":"52 1","pages":"Article 101016"},"PeriodicalIF":0.1,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142722615","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Violencia obstétrica: primera, segunda y tercera víctima 产科暴力:第一、第二和第三受害者
IF 0.1 Q4 OBSTETRICS & GYNECOLOGY Pub Date : 2025-01-01 Epub Date: 2024-10-15 DOI: 10.1016/j.gine.2024.101001
L. Guillén Vargas , E.M. Aragoneses Tiburcio , M.J. Galván León , J.M. Martínez-Sánchez
{"title":"Violencia obstétrica: primera, segunda y tercera víctima","authors":"L. Guillén Vargas ,&nbsp;E.M. Aragoneses Tiburcio ,&nbsp;M.J. Galván León ,&nbsp;J.M. Martínez-Sánchez","doi":"10.1016/j.gine.2024.101001","DOIUrl":"10.1016/j.gine.2024.101001","url":null,"abstract":"","PeriodicalId":41294,"journal":{"name":"Clinica e Investigacion en Ginecologia y Obstetricia","volume":"52 1","pages":"Article 101001"},"PeriodicalIF":0.1,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142437902","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Management of thoracic neuropathic pain with an ESP block in a pregnant patient 用 ESP 阻滞治疗怀孕患者的胸椎神经痛
IF 0.1 Q4 OBSTETRICS & GYNECOLOGY Pub Date : 2025-01-01 Epub Date: 2024-10-11 DOI: 10.1016/j.gine.2024.101004
L. Arce Gálvez , R.E. Valencia Gómez , A. Ceballos Vejarano , J. Daes Mora , D.A. Méndez Vega

Introduction

The erector spinae plane block is a useful intervention in the management of somatic and visceral nociceptive pain at different spinal levels. Studies of its use during pregnancy are still limited, however, it has shown interesting results in the management of non-obstetric pain during pregnancy.

Clinical case

We present the case of a 27.5-week pregnant woman with a history of pancreatitis and a thoracotomy with neuropathic pain at intercostal level and repeated emetic symptoms who was taken to an ESP at T6 level with a sudden improvement of her symptomatology, without side effects or maternal–fetal damage.

Conclusion

This is the first description of the use of ESP blockade in intercostal pain during gestation, where we highlight its clinical efficacy and maternal–fetal safety profile.
导言竖脊肌平面阻滞是治疗不同脊柱水平的躯体和内脏痛觉疼痛的有效干预方法。然而,它在治疗妊娠期非产科疼痛方面取得了令人感兴趣的效果。我们介绍了一例妊娠 27.5 周的孕妇,她曾有胰腺炎和开胸手术史,并伴有肋间神经性疼痛和反复呕吐症状,在接受 T6 水平的 ESP 治疗后,症状突然改善,且无副作用或母胎损伤。
{"title":"Management of thoracic neuropathic pain with an ESP block in a pregnant patient","authors":"L. Arce Gálvez ,&nbsp;R.E. Valencia Gómez ,&nbsp;A. Ceballos Vejarano ,&nbsp;J. Daes Mora ,&nbsp;D.A. Méndez Vega","doi":"10.1016/j.gine.2024.101004","DOIUrl":"10.1016/j.gine.2024.101004","url":null,"abstract":"<div><h3>Introduction</h3><div>The erector spinae plane block is a useful intervention in the management of somatic and visceral nociceptive pain at different spinal levels. Studies of its use during pregnancy are still limited, however, it has shown interesting results in the management of non-obstetric pain during pregnancy.</div></div><div><h3>Clinical case</h3><div>We present the case of a 27.5-week pregnant woman with a history of pancreatitis and a thoracotomy with neuropathic pain at intercostal level and repeated emetic symptoms who was taken to an ESP at T6 level with a sudden improvement of her symptomatology, without side effects or maternal–fetal damage.</div></div><div><h3>Conclusion</h3><div>This is the first description of the use of ESP blockade in intercostal pain during gestation, where we highlight its clinical efficacy and maternal–fetal safety profile.</div></div>","PeriodicalId":41294,"journal":{"name":"Clinica e Investigacion en Ginecologia y Obstetricia","volume":"52 1","pages":"Article 101004"},"PeriodicalIF":0.1,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142422618","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Diagnóstico de cáncer renal metastásico en gestante a través de lesiones cutáneas: descripción de un caso clínico 通过皮肤病变诊断孕妇患有转移性肾癌:病例报告描述
IF 0.1 Q4 OBSTETRICS & GYNECOLOGY Pub Date : 2025-01-01 Epub Date: 2024-10-05 DOI: 10.1016/j.gine.2024.100999
A. Ramírez Castán , M.J. Cuerva González , J.L. Bartha Rasero

Introduction

Gestational cancer affects approximately 1 in 1,000 pregnant women, with renal cell carcinoma (RCC) being the most common in the urinary tract. RCC dissemination can include cutaneous metastases in 2.8-6.8% of cases. A multidisciplinary approach to RCC during pregnancy is crucial due to diagnostic and therapeutic challenges that can impact maternal and neonatal outcomes.

Symptoms and Clinical Findings

A 15-week pregnant woman presents with asymptomatic cutaneous lesions for 4 months. Physical examination reveals two erythematous-violaceous nodules in the right hypochondrium and two in the right thigh, all adherent to deep planes and without palpable lymphadenopathy.

Diagnosis, Therapeutic Intervention, and Results

Excisional skin biopsy with immunohistochemical and molecular studies suggests cutaneous metastasis of papillary-pattern renal carcinoma. Nuclear magnetic resonance reveals multiple metastatic implants and lymphadenopathies. Despite recommendations to terminate pregnancy for targeted therapy, the patient chooses to continue. At week 31, a cesarean section is performed due to maternal clinical deterioration from disease progression. Oncologic treatment with Cabozantinib begins postpartum. Six months later, the patient remains stable with significant lesion improvement.

Conclusion

Diagnosing cancer during pregnancy presents a complex challenge, balancing maternal prognosis with fetal health is critical. Emphasizing a multidisciplinary approach and early consultation optimizes both clinical and emotional management.
导言妊娠期癌症约影响到千分之一的孕妇,其中肾细胞癌(RCC)在泌尿道最为常见。在2.8%-6.8%的病例中,RCC可发生皮肤转移。由于诊断和治疗方面的挑战可能会影响孕产妇和新生儿的预后,因此对妊娠期 RCC 采用多学科方法至关重要。体格检查发现右侧下腹部和右侧大腿分别有两个红斑橘皮样结节,所有结节均与深面粘连,未触及淋巴结肿大。诊断、治疗干预和结果切除皮肤活检及免疫组化和分子研究提示乳头状肾癌皮肤转移。核磁共振显示有多个转移性植入物和淋巴结病变。尽管医生建议患者终止妊娠以接受靶向治疗,但患者仍选择继续妊娠。第 31 周时,由于疾病进展导致产妇临床症状恶化,患者接受了剖腹产手术。产后开始接受卡博替尼(Cabozantinib)的肿瘤治疗。结论妊娠期癌症诊断是一项复杂的挑战,平衡母体预后和胎儿健康至关重要。强调多学科方法和早期咨询可优化临床和情绪管理。
{"title":"Diagnóstico de cáncer renal metastásico en gestante a través de lesiones cutáneas: descripción de un caso clínico","authors":"A. Ramírez Castán ,&nbsp;M.J. Cuerva González ,&nbsp;J.L. Bartha Rasero","doi":"10.1016/j.gine.2024.100999","DOIUrl":"10.1016/j.gine.2024.100999","url":null,"abstract":"<div><h3>Introduction</h3><div>Gestational cancer affects approximately 1 in 1,000 pregnant women, with renal cell carcinoma (RCC) being the most common in the urinary tract. RCC dissemination can include cutaneous metastases in 2.8-6.8% of cases. A multidisciplinary approach to RCC during pregnancy is crucial due to diagnostic and therapeutic challenges that can impact maternal and neonatal outcomes.</div></div><div><h3>Symptoms and Clinical Findings</h3><div>A 15-week pregnant woman presents with asymptomatic cutaneous lesions for 4 months. Physical examination reveals two erythematous-violaceous nodules in the right hypochondrium and two in the right thigh, all adherent to deep planes and without palpable lymphadenopathy.</div></div><div><h3>Diagnosis, Therapeutic Intervention, and Results</h3><div>Excisional skin biopsy with immunohistochemical and molecular studies suggests cutaneous metastasis of papillary-pattern renal carcinoma. Nuclear magnetic resonance reveals multiple metastatic implants and lymphadenopathies. Despite recommendations to terminate pregnancy for targeted therapy, the patient chooses to continue. At week 31, a cesarean section is performed due to maternal clinical deterioration from disease progression. Oncologic treatment with Cabozantinib begins postpartum. Six months later, the patient remains stable with significant lesion improvement.</div></div><div><h3>Conclusion</h3><div>Diagnosing cancer during pregnancy presents a complex challenge, balancing maternal prognosis with fetal health is critical. Emphasizing a multidisciplinary approach and early consultation optimizes both clinical and emotional management.</div></div>","PeriodicalId":41294,"journal":{"name":"Clinica e Investigacion en Ginecologia y Obstetricia","volume":"52 1","pages":"Article 100999"},"PeriodicalIF":0.1,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142423093","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Restos ovulares y placentarios (ROP) y nódulo del lecho placentario (NLP) en un istmocele tras un parto vaginal: diagnóstico y corrección laparoscópica 阴道分娩后峡部畸形中的卵巢和胎盘残留物(OPR)以及胎盘床结节(PLN):诊断和腹腔镜矫正术
IF 0.1 Q4 OBSTETRICS & GYNECOLOGY Pub Date : 2025-01-01 Epub Date: 2024-08-23 DOI: 10.1016/j.gine.2024.100994
L. Moreno Leñero , A. Morales Vicente , S. Moner Marín , P. Millares Rubio , N. Santonja López , Y. García Sánchez , J. Gilabert Estellés

Introduction

An isthmocele is a disruption of the myometrium that creates a cavity at the level of the hysterorrhaphy because of an impaired cicatrization from a previous caesarean section. In addition to several obstetric and fertility complications, it is possible the presence of retained products of conception inside it. We present the case of an isthmocele without previous cesarean section, with retained products of conception and a placental site nodule.

Symptoms and clinical findings

We present a clinical case of a 32-year-old woman, with no history of previous cesarean section, who consulted due to the presence of latent hypogastric pain. After the initial examination and hysteroscopy, the presence of an isthmocele with retained products of conception was revealed.

Therapeutic interventions

After laparoscopic correction of the isthmocele, the anatomopathological findings showed the presence of a placental site nodule, a benign entity whose atypical variant is related to epithelioid trophoblastic tumor, which is the rarest form of gestational trophoblastic tumor.

Results

After the surgical procedure, the patient remains asymptomatic and without any additional treatment.

导言峡部畸形是子宫肌层的破坏,由于之前的剖腹产手术造成的瘢痕形成障碍,在子宫峡部形成一个空腔。除了一些产科和生育方面的并发症外,还可能有受孕产物残留其中。我们介绍了一例既往无剖宫产史的峡部妊娠,伴有受孕产物滞留和胎盘部位结节的病例。症状和临床发现我们介绍了一例临床病例,患者为一名 32 岁女性,既往无剖宫产史,因出现潜伏性下腹疼痛而就诊。治疗干预在腹腔镜下矫正峡部后,解剖病理结果显示存在胎盘部位结节,这是一种良性实体,其非典型变异与上皮样滋养细胞肿瘤有关,而上皮样滋养细胞肿瘤是妊娠滋养细胞肿瘤中最罕见的形式。
{"title":"Restos ovulares y placentarios (ROP) y nódulo del lecho placentario (NLP) en un istmocele tras un parto vaginal: diagnóstico y corrección laparoscópica","authors":"L. Moreno Leñero ,&nbsp;A. Morales Vicente ,&nbsp;S. Moner Marín ,&nbsp;P. Millares Rubio ,&nbsp;N. Santonja López ,&nbsp;Y. García Sánchez ,&nbsp;J. Gilabert Estellés","doi":"10.1016/j.gine.2024.100994","DOIUrl":"10.1016/j.gine.2024.100994","url":null,"abstract":"<div><h3>Introduction</h3><p>An isthmocele is a disruption of the myometrium that creates a cavity at the level of the hysterorrhaphy because of an impaired cicatrization from a previous caesarean section. In addition to several obstetric and fertility complications, it is possible the presence of retained products of conception inside it. We present the case of an isthmocele without previous cesarean section, with retained products of conception and a placental site nodule.</p></div><div><h3>Symptoms and clinical findings</h3><p>We present a clinical case of a 32-year-old woman, with no history of previous cesarean section, who consulted due to the presence of latent hypogastric pain. After the initial examination and hysteroscopy, the presence of an isthmocele with retained products of conception was revealed.</p></div><div><h3>Therapeutic interventions</h3><p>After laparoscopic correction of the isthmocele, the anatomopathological findings showed the presence of a placental site nodule, a benign entity whose atypical variant is related to epithelioid trophoblastic tumor, which is the rarest form of gestational trophoblastic tumor.</p></div><div><h3>Results</h3><p>After the surgical procedure, the patient remains asymptomatic and without any additional treatment.</p></div>","PeriodicalId":41294,"journal":{"name":"Clinica e Investigacion en Ginecologia y Obstetricia","volume":"52 1","pages":"Article 100994"},"PeriodicalIF":0.1,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142048525","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Parecoxib vs. Dexketoprofeno, en combinación con paracetamol, como analgesia adicional en pacientes que reciben morfina neuraxial para el alivio del dolor postoperatorio en la cesárea: estudio prospectivo, aleatorizado, controlado, doble ciego 帕瑞昔布与右酮洛芬联合扑热息痛作为接受神经吗啡治疗的剖腹产术后镇痛患者的额外镇痛:一项前瞻性、随机对照、双盲研究。
IF 0.1 Q4 OBSTETRICS & GYNECOLOGY Pub Date : 2025-01-01 Epub Date: 2024-08-23 DOI: 10.1016/j.gine.2024.100993
L. Bodden, O. Reyes, G. Cárdenas

Objective

To evaluate the effectiveness of parecoxib vs. dexketoprofen, in combination with paracetamol, as additional analgesia in patients receiving neuraxial morphine for postoperative pain relief in cesarean section.

Methods

A total of 380 patients scheduled for a cesarean section received neuraxial morphine for pain management. After the procedure, they were randomized to receive, as additional analgesia, 1 g of paracetamol intravenously every 6 h in combination with either 40 mg of parecoxib intravenously every 12 h or 50 mg of dexketoprofen intravenously every 8 h. A Visual Analog Scale (VAS) was used for evaluation of pain intensity at 12 and 24 h post-operative. Also, the need for additional analgesics, the time (h) required to start patient mobilization and the presence of adverse effects were recorded.

Results

No statistical differences were found between groups in pain intensity, using the VAS-Pain score at 12 h [(Parecoxib vs. Dexketoprofen): 2.76(4.03) vs 2.97(4.34); p = 0.39)], at 24 h [(Parecoxib vs. Dexketoprofen): 2.47(4.62) vs 2.84(5.20); p = 0.11)] or in the need for additional analgesics at 12 h [(Parecoxib vs. Dexketoprofen): 4.21% vs 5.79%; RR = 0.73, 95% CI: 0.33 to 1.77; p = 0.31)] or at 24 h [(Parecoxib vs. Dexketoprofen): 5.79% vs 4.21%; RR = 1.38, 95% CI: 0.57 to 3.34; p = 0.31)]. There were no differences in mobilization time or in the development of adverse effects.

Conclusion

There are no differences concerning the effectiveness of parecoxib vs. dexketoprofen, in combination with paracetamol as additional analgesia in patients receiving neuraxial morphine, for postoperative pain relief in cesarean section.

目的 评价帕瑞昔布与右酮洛芬联合扑热息痛作为剖宫产术后吗啡镇痛患者的额外镇痛的有效性。方法 共有 380 名计划接受剖宫产术的患者接受了吗啡镇痛。术后,他们被随机分配接受额外镇痛,即每 6 小时静脉注射 1 克扑热息痛,同时每 12 小时静脉注射 40 毫克帕瑞昔布或每 8 小时静脉注射 50 毫克右酮洛芬。此外,还记录了对额外镇痛药的需求、患者开始活动所需的时间(小时)以及不良反应的出现情况。结果根据术后 12 小时的 VAS 疼痛评分[(帕瑞昔布 vs. 右酮洛芬)],未发现组间疼痛强度存在统计学差异。帕瑞昔布 vs 右酮洛芬):2.76(4.03) vs 2.97(4.34);p = 0.39)]、24 h [(帕瑞昔布 vs 右酮洛芬):2.47(4.62) vs 2.84(5.20);p = 0.11)]的疼痛强度或 12 h 的额外镇痛药需求方面均无统计学差异[(帕瑞昔布 vs 右酮洛芬):4.21% vs 5.79%]:4.21% vs 5.79%; RR = 0.73, 95% CI: 0.33 to 1.77; p = 0.31)]或在 24 小时后[(帕瑞昔布 vs 右酮洛芬):5.79% vs 4.21%; RR = 0.73, 95% CI: 0.33 to 1.77; p = 0.31]:5.79% vs 4.21%; RR = 1.38, 95% CI: 0.57 to 3.34; p = 0.31)]。结论帕瑞昔布与右酮洛芬联合使用,作为接受神经吗啡治疗的患者的额外镇痛药物,在剖宫产术后镇痛效果方面没有差异。
{"title":"Parecoxib vs. Dexketoprofeno, en combinación con paracetamol, como analgesia adicional en pacientes que reciben morfina neuraxial para el alivio del dolor postoperatorio en la cesárea: estudio prospectivo, aleatorizado, controlado, doble ciego","authors":"L. Bodden,&nbsp;O. Reyes,&nbsp;G. Cárdenas","doi":"10.1016/j.gine.2024.100993","DOIUrl":"10.1016/j.gine.2024.100993","url":null,"abstract":"<div><h3>Objective</h3><p>To evaluate the effectiveness of parecoxib vs. dexketoprofen, in combination with paracetamol, as additional analgesia in patients receiving neuraxial morphine for postoperative pain relief in cesarean section.</p></div><div><h3>Methods</h3><p>A total of 380 patients scheduled for a cesarean section received neuraxial morphine for pain management. After the procedure, they were randomized to receive, as additional analgesia, 1<!--> <!-->g of paracetamol intravenously every 6<!--> <!-->h in combination with either 40<!--> <!-->mg of parecoxib intravenously every 12<!--> <!-->h or 50<!--> <!-->mg of dexketoprofen intravenously every 8<!--> <!-->h. A Visual Analog Scale (VAS) was used for evaluation of pain intensity at 12 and 24<!--> <!-->h post-operative. Also, the need for additional analgesics, the time (h) required to start patient mobilization and the presence of adverse effects were recorded.</p></div><div><h3>Results</h3><p>No statistical differences were found between groups in pain intensity, using the VAS-Pain score at 12<!--> <!-->h [(Parecoxib vs. Dexketoprofen): 2.76(4.03) vs 2.97(4.34); p<!--> <!-->=<!--> <!-->0.39)], at 24<!--> <!-->h [(Parecoxib vs. Dexketoprofen): 2.47(4.62) vs 2.84(5.20); p<!--> <!-->=<!--> <!-->0.11)] or in the need for additional analgesics at 12<!--> <!-->h [(Parecoxib vs. Dexketoprofen): 4.21% vs 5.79%; RR<!--> <!-->=<!--> <!-->0.73, 95% CI: 0.33 to 1.77; p<!--> <!-->=<!--> <!-->0.31)] or at 24<!--> <!-->h [(Parecoxib vs. Dexketoprofen): 5.79% vs 4.21%; RR<!--> <!-->=<!--> <!-->1.38, 95% CI: 0.57 to 3.34; p<!--> <!-->=<!--> <!-->0.31)]. There were no differences in mobilization time or in the development of adverse effects.</p></div><div><h3>Conclusion</h3><p>There are no differences concerning the effectiveness of parecoxib vs. dexketoprofen, in combination with paracetamol as additional analgesia in patients receiving neuraxial morphine, for postoperative pain relief in cesarean section.</p></div>","PeriodicalId":41294,"journal":{"name":"Clinica e Investigacion en Ginecologia y Obstetricia","volume":"52 1","pages":"Article 100993"},"PeriodicalIF":0.1,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142048524","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Factores asociados a la depresión posparto en puérperas de un hospital peruano 秘鲁一家医院产后妇女产后抑郁的相关因素
IF 0.1 Q4 OBSTETRICS & GYNECOLOGY Pub Date : 2024-10-01 Epub Date: 2024-08-16 DOI: 10.1016/j.gine.2024.100986
H.R. Leveau-Bartra , J.R. Chávez-Navarro , L.A. Calle-Vilca , H.A. Guerrero-Ortiz , C.E. Mejia-Lengua , B.M. Luján-Divizzia , I.K. Leveau-Vásquez , N.L. Medina-Vásquez , H.I. Leveau-Vásquez , F.K. Medina-Vásquez

Background

Postpartum depression can lead to situations in new mothers that affect baby care, impacting their feeding by reducing adherence to exclusive breastfeeding. Therefore, it is important to identify the factors associated with this condition.

Objective

To determine which sociodemographic factors are associated with postpartum depression in postpartum women at a Peruvian hospital.

Materials and methods

Observational, cross-sectional, and analytical research.

Design

Case-control research design.

Site

Regional Hospital of Ica-Peru.

Participants

A total of 173 cases (postpartum women at risk of postpartum depression) were studied and compared with 173 controls (postpartum women without risk of postpartum depression). All participants were surveyed between the months of May and October 2022, 15 to 30 days after delivery.

Interventions

Survey.

Main measures

Edinburgh Postnatal Depression Scale to obtain the metric of the dependent variable, and a general data sheet to obtain independent variables. The cutoff point for the Edinburgh Scale was ≥ 13.

Results

The prevalence of postpartum depression was 18.8% (95% CI = 16.3-21.3). The associated factors were: Age under 20 years OR: 2.2 (95% CI: 1.4-3.4) p = 0.001. Higher education level OR: 4.5 (95% CI: 2.8-7.0) p = 0.000. Single marital status OR: 4.4 (95% CI: 2.8-6.9) p = 0.000. Poor relationship with partner OR: 3.9 (95% CI: 2.4-6.1) p = 0.000. Use of Psychotropic drugs OR: 2.7 (95% CI: 1.7-4.4) p = 0.000. Complications during labor OR: 2.6 (95% CI: 1.6-4.3) p = 0.000. Cesarean delivery OR: 3.3 (95% CI: 2.1-5.1) p = 0.000. History of COVID-19 infection during pregnancy OR: 2.7 (95% CI: 1.7-4.2) p = 0.000. Employment status OR: 3.2 (95% CI: 2.1-5.0) p = 0.000.

Conclusion

Postpartum depression is associated with sociodemographic variables in the patient's environment that require timely intervention to reduce negative effects on both the mother and the child.

.

背景产后抑郁症会导致新妈妈出现影响婴儿护理的情况,并通过降低纯母乳喂养的坚持率来影响她们的喂养。材料与方法观察性、横断面和分析性研究设计病例对照研究设计研究地点秘鲁伊卡地区医院参与者共研究了 173 例病例(有产后抑郁风险的产后妇女),并与 173 例对照(无产后抑郁风险的产后妇女)进行了比较。干预措施调查。主要测量指标爱丁堡产后抑郁量表用于获取因变量的度量,一般数据表用于获取自变量。结果产后抑郁症的患病率为 18.8%(95% CI = 16.3-21.3)。相关因素如下年龄小于 20 岁 OR:2.2 (95% CI:1.4-3.4) p = 0.001。教育程度较高 OR:4.5 (95% CI: 2.8-7.0) p = 0.000。单身婚姻状况 OR:4.4 (95% CI: 2.8-6.9) p = 0.000。与伴侣关系不佳 OR:3.9 (95% CI: 2.4-6.1) p = 0.000。使用精神药物 OR:2.7(95% CI:1.7-4.4)p = 0.000。分娩并发症 OR:2.6(95% CI:1.6-4.3)p = 0.000。剖宫产 OR:3.3(95% CI:2.1-5.1) p = 0.000。孕期有 COVID-19 感染史 OR:2.7(95% CI:1.7-4.2)P = 0.000。就业状况 OR:产后抑郁与患者所处环境中的社会人口变量有关,需要及时干预以减少对母婴的负面影响。
{"title":"Factores asociados a la depresión posparto en puérperas de un hospital peruano","authors":"H.R. Leveau-Bartra ,&nbsp;J.R. Chávez-Navarro ,&nbsp;L.A. Calle-Vilca ,&nbsp;H.A. Guerrero-Ortiz ,&nbsp;C.E. Mejia-Lengua ,&nbsp;B.M. Luján-Divizzia ,&nbsp;I.K. Leveau-Vásquez ,&nbsp;N.L. Medina-Vásquez ,&nbsp;H.I. Leveau-Vásquez ,&nbsp;F.K. Medina-Vásquez","doi":"10.1016/j.gine.2024.100986","DOIUrl":"10.1016/j.gine.2024.100986","url":null,"abstract":"<div><h3>Background</h3><p>Postpartum depression can lead to situations in new mothers that affect baby care, impacting their feeding by reducing adherence to exclusive breastfeeding. Therefore, it is important to identify the factors associated with this condition.</p></div><div><h3>Objective</h3><p>To determine which sociodemographic factors are associated with postpartum depression in postpartum women at a Peruvian hospital.</p></div><div><h3>Materials and methods</h3><p>Observational, cross-sectional, and analytical research.</p></div><div><h3>Design</h3><p>Case-control research design.</p></div><div><h3>Site</h3><p>Regional Hospital of Ica-Peru.</p></div><div><h3>Participants</h3><p>A total of 173 cases (postpartum women at risk of postpartum depression) were studied and compared with 173 controls (postpartum women without risk of postpartum depression). All participants were surveyed between the months of May and October 2022, 15 to 30 days after delivery.</p></div><div><h3>Interventions</h3><p>Survey.</p></div><div><h3>Main measures</h3><p>Edinburgh Postnatal Depression Scale to obtain the metric of the dependent variable, and a general data sheet to obtain independent variables. The cutoff point for the Edinburgh Scale was ≥ 13.</p></div><div><h3>Results</h3><p>The prevalence of postpartum depression was 18.8% (95% <span>C</span>I<!--> <!-->=<!--> <!-->16.3-21.3). The associated factors were: Age under 20 years OR: 2.2 (95% CI: 1.4-3.4) p<!--> <!-->=<!--> <!-->0.001. Higher education level OR: 4.5 (95% CI: 2.8-7.0) p<!--> <!-->=<!--> <!-->0.000. Single marital status OR: 4.4 (95% CI: 2.8-6.9) p<!--> <!-->=<!--> <!-->0.000. Poor relationship with partner OR: 3.9 (95% CI: 2.4-6.1) p<!--> <!-->=<!--> <!-->0.000. Use of Psychotropic drugs OR: 2.7 (95% CI: 1.7-4.4) p<!--> <!-->=<!--> <!-->0.000. Complications during labor OR: 2.6 (95% CI: 1.6-4.3) p<!--> <!-->=<!--> <!-->0.000. Cesarean delivery OR: 3.3 (95% CI: 2.1-5.1) p<!--> <!-->=<!--> <!-->0.000. History of COVID-19 infection during pregnancy OR: 2.7 (95% CI: 1.7-4.2) p<!--> <!-->=<!--> <!-->0.000. Employment status OR: 3.2 (95% CI: 2.1-5.0) p<!--> <!-->=<!--> <!-->0.000.</p></div><div><h3>Conclusion</h3><p>Postpartum depression is associated with sociodemographic variables in the patient's environment that require timely intervention to reduce negative effects on both the mother and the child.</p><p>.</p></div>","PeriodicalId":41294,"journal":{"name":"Clinica e Investigacion en Ginecologia y Obstetricia","volume":"51 4","pages":"Article 100986"},"PeriodicalIF":0.1,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0210573X24000492/pdfft?md5=0e3ebe775176163e2a9d3140953f22d4&pid=1-s2.0-S0210573X24000492-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141993895","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Synchronous presentation of endometrial adenocarcinoma and incidental paratubal borderline serous tumor: A rare case report 子宫内膜腺癌与附带的管旁边界浆液性肿瘤同时出现:罕见病例报告
IF 0.1 Q4 OBSTETRICS & GYNECOLOGY Pub Date : 2024-10-01 Epub Date: 2024-08-20 DOI: 10.1016/j.gine.2024.100989
A.A. Khan, C. Ahluwalia, S. Ahuja

Introduction

Paratubal cysts, commonly benign and incidentally found during hysterectomy or salpingectomy, are often termed “hydatid cysts of Morgagni.” While most are benign, borderline and malignant subtypes are rare. This report presents an unusual case of synchronous malignancies involving an endometrioid adenocarcinoma and a paratubal borderline serous tumor, emphasizing the need for careful examination of paratubal cysts.

Main symptoms and/or clinical findings

A 61-year-old postmenopausal woman presented with two months of vaginal bleeding and lower abdominal pain. Elevated CEA and CA 19-9 levels were noted. Ultrasonography showed thickened endometrium and moderate pyometra, and MRI revealed a lesion in the upper endometrium involving the myometrium without extrauterine extension. An endometrial biopsy indicated endometrial intraepithelial neoplasia.

Main diagnoses, therapeutic interventions, and outcomes

The patient underwent a staging laparotomy, bilateral salpingo-oophorectomy, hysterectomy, and pelvic lymphadenectomy. Histopathology confirmed endometrioid adenocarcinoma (FIGO grade II, stage IB) and identified a left paratubal cyst with borderline serous tumor features. Immunohistochemical analysis supported these findings. The post-operative period was uneventful, and the patient remains under follow-up with no signs of recurrence or metastasis.

Conclusion

This case underscores the importance of thorough examination of paratubal cysts. The rare coexistence of endometrioid adenocarcinoma with a borderline serous paratubal tumor highlights the necessity for detailed histopathological and immunohistochemical evaluation in synchronous malignancies. Such meticulous examination ensures accurate diagnosis and appropriate management, potentially enhancing patient outcomes.

导言耻骨旁囊肿通常是良性的,在子宫切除术或输卵管切除术中偶然发现,通常被称为 "莫尔加尼氏包虫囊肿"。虽然大多数是良性的,但边缘型和恶性亚型却很罕见。本报告介绍了一例不寻常的同步恶性肿瘤病例,涉及子宫内膜样腺癌和管旁边缘性浆液性肿瘤,强调了对管旁囊肿进行仔细检查的必要性。发现CEA和CA 19-9水平升高。超声波检查显示子宫内膜增厚和中度脓肿,核磁共振成像显示子宫内膜上部病变累及子宫肌层,但无宫外延伸。患者接受了分期开腹手术、双侧输卵管切除术、子宫切除术和盆腔淋巴结切除术。组织病理学证实为子宫内膜样腺癌(FIGO II级,IB期),并发现左侧耻骨旁囊肿具有边缘浆液性肿瘤特征。免疫组化分析证实了这些结果。该病例强调了彻底检查输卵管旁囊肿的重要性。子宫内膜样腺癌与边缘性浆液性输卵管旁肿瘤并存的罕见病例强调了对同步恶性肿瘤进行详细组织病理学和免疫组化评估的必要性。这种细致的检查可确保准确的诊断和适当的治疗,从而改善患者的预后。
{"title":"Synchronous presentation of endometrial adenocarcinoma and incidental paratubal borderline serous tumor: A rare case report","authors":"A.A. Khan,&nbsp;C. Ahluwalia,&nbsp;S. Ahuja","doi":"10.1016/j.gine.2024.100989","DOIUrl":"10.1016/j.gine.2024.100989","url":null,"abstract":"<div><h3>Introduction</h3><p>Paratubal cysts, commonly benign and incidentally found during hysterectomy or salpingectomy, are often termed “hydatid cysts of Morgagni.” While most are benign, borderline and malignant subtypes are rare. This report presents an unusual case of synchronous malignancies involving an endometrioid adenocarcinoma and a paratubal borderline serous tumor, emphasizing the need for careful examination of paratubal cysts.</p></div><div><h3>Main symptoms and/or clinical findings</h3><p>A 61-year-old postmenopausal woman presented with two months of vaginal bleeding and lower abdominal pain. Elevated CEA and CA 19-9 levels were noted. Ultrasonography showed thickened endometrium and moderate pyometra, and MRI revealed a lesion in the upper endometrium involving the myometrium without extrauterine extension. An endometrial biopsy indicated endometrial intraepithelial neoplasia.</p></div><div><h3>Main diagnoses, therapeutic interventions, and outcomes</h3><p>The patient underwent a staging laparotomy, bilateral salpingo-oophorectomy, hysterectomy, and pelvic lymphadenectomy. Histopathology confirmed endometrioid adenocarcinoma (FIGO grade II, stage IB) and identified a left paratubal cyst with borderline serous tumor features. Immunohistochemical analysis supported these findings. The post-operative period was uneventful, and the patient remains under follow-up with no signs of recurrence or metastasis.</p></div><div><h3>Conclusion</h3><p>This case underscores the importance of thorough examination of paratubal cysts. The rare coexistence of endometrioid adenocarcinoma with a borderline serous paratubal tumor highlights the necessity for detailed histopathological and immunohistochemical evaluation in synchronous malignancies. Such meticulous examination ensures accurate diagnosis and appropriate management, potentially enhancing patient outcomes.</p></div>","PeriodicalId":41294,"journal":{"name":"Clinica e Investigacion en Ginecologia y Obstetricia","volume":"51 4","pages":"Article 100989"},"PeriodicalIF":0.1,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142011880","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Preeclampsia como factor de riesgo de enfermedad cardiovascular en el futuro: etiopatogenia e implicación en la práctica clínica 子痫前期是未来心血管疾病的危险因素:发病机制和对临床实践的影响
IF 0.1 Q4 OBSTETRICS & GYNECOLOGY Pub Date : 2024-10-01 Epub Date: 2024-07-09 DOI: 10.1016/j.gine.2024.100972
M. Moreno López

Preeclampsia is a gestational disorder that associates arterial hypertension and organic disfunction and can have adverse consequence to both mother and fetus in the short term. The main factor implicated in its pathogenesis is an anormal placentation leading to endothelial dysfunction, as well as to the dysregulation of physiological pathways. Last evidence suggests that preeclampsia can also lead to long-terms outcomes, such an increase incidence of chronic disease, renal dysfunction and increased cardiovascular risk. This paper reviews the long-term cardiovascular consequences, their pathogenesis and the implications for clinical practice.

子痫前期是一种伴有动脉高血压和器质性功能障碍的妊娠疾病,短期内会对母亲和胎儿造成不良后果。其发病机制的主要因素是胎盘异常导致内皮功能失调以及生理途径失调。最新证据表明,子痫前期也会导致长期后果,如慢性疾病发病率增加、肾功能障碍和心血管风险增加。本文回顾了心血管疾病的长期后果、发病机制以及对临床实践的影响。
{"title":"Preeclampsia como factor de riesgo de enfermedad cardiovascular en el futuro: etiopatogenia e implicación en la práctica clínica","authors":"M. Moreno López","doi":"10.1016/j.gine.2024.100972","DOIUrl":"https://doi.org/10.1016/j.gine.2024.100972","url":null,"abstract":"<div><p>Preeclampsia is a gestational disorder that associates arterial hypertension and organic disfunction and can have adverse consequence to both mother and fetus in the short term. The main factor implicated in its pathogenesis is an anormal placentation leading to endothelial dysfunction, as well as to the dysregulation of physiological pathways. Last evidence suggests that preeclampsia can also lead to long-terms outcomes, such an increase incidence of chronic disease, renal dysfunction and increased cardiovascular risk. This paper reviews the long-term cardiovascular consequences, their pathogenesis and the implications for clinical practice.</p></div>","PeriodicalId":41294,"journal":{"name":"Clinica e Investigacion en Ginecologia y Obstetricia","volume":"51 4","pages":"Article 100972"},"PeriodicalIF":0.1,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141582057","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Descripción de un caso. Duplicación del cromosoma 1q: diagnóstico prenatal, manifestaciones ecográficas y pronóstico perinatal 病例报告。染色体 1q 重复:产前诊断、超声波检查结果和围产期预后。
IF 0.1 Q4 OBSTETRICS & GYNECOLOGY Pub Date : 2024-10-01 Epub Date: 2024-06-22 DOI: 10.1016/j.gine.2024.100968
M.C. Restrepo-Guarnizo , I. Dávila Neri , R.L. Aragón Mendoza

Introduction

Mosaicism due to duplication of chromosome 1q is recognized as a cytogenetic anomaly, characterized by low frequency and few cases reported in the literature.

Clinical findings

In this case, we present a primigravida patient at 24 weeks of pregnancy, with a fetus displaying abnormal ultrasound findings. These include ventriculomegaly, micrognathia, hypotelorism, and associated diaphragmatic hernia.

Primary diagnoses

Amniocentesis was performed, and karyotype analysis revealed a prenatal diagnosis of mos 46,XY,dup(1)(q23q44)[19]/46,XY[41] mosaicism. Subsequently, the patient experienced preterm delivery with early perinatal demise.

Therapeutic interventions and outcomes

Due to the lack of evidence regarding fetal therapy and the prenatal diagnosis of this condition, postnatal assessment was awaited for appropriate therapeutic management. Subsequently, the patient had preterm delivery with early perinatal death.

Conclusion

Heterogeneity of findings is observed to depend on the size and location of the chromosomal alteration, and factors such as the concurrent development of diaphragmatic hernia are associated with a poorer prognosis and higher rates of mortality due to the degree of pulmonary hypoplasia.

导言1q染色体重复导致的马赛克现象是公认的细胞遗传学异常,其特点是发生率低,文献报道的病例很少。初步诊断进行了羊膜腔穿刺,核型分析显示产前诊断为镶嵌型 46,XY,dup(1)(q23q44)[19]/46,XY[41]。治疗干预和结果由于缺乏有关胎儿治疗和产前诊断的证据,患者需要等待产后评估以采取适当的治疗措施。随后,患者出现早产,并在围产期早期死亡。结论观察到的结果异质性取决于染色体改变的大小和位置,而同时出现膈疝等因素与较差的预后和较高的死亡率有关,这与肺发育不全的程度有关。
{"title":"Descripción de un caso. Duplicación del cromosoma 1q: diagnóstico prenatal, manifestaciones ecográficas y pronóstico perinatal","authors":"M.C. Restrepo-Guarnizo ,&nbsp;I. Dávila Neri ,&nbsp;R.L. Aragón Mendoza","doi":"10.1016/j.gine.2024.100968","DOIUrl":"https://doi.org/10.1016/j.gine.2024.100968","url":null,"abstract":"<div><h3>Introduction</h3><p>Mosaicism due to duplication of chromosome 1q is recognized as a cytogenetic anomaly, characterized by low frequency and few cases reported in the literature.</p></div><div><h3>Clinical findings</h3><p>In this case, we present a primigravida patient at 24 weeks of pregnancy, with a fetus displaying abnormal ultrasound findings. These include ventriculomegaly, micrognathia, hypotelorism, and associated diaphragmatic hernia.</p></div><div><h3>Primary diagnoses</h3><p>Amniocentesis was performed, and karyotype analysis revealed a prenatal diagnosis of mos 46,XY,dup(1)(q23q44)[19]/46,XY[41] mosaicism. Subsequently, the patient experienced preterm delivery with early perinatal demise.</p></div><div><h3>Therapeutic interventions and outcomes</h3><p>Due to the lack of evidence regarding fetal therapy and the prenatal diagnosis of this condition, postnatal assessment was awaited for appropriate therapeutic management. Subsequently, the patient had preterm delivery with early perinatal death.</p></div><div><h3>Conclusion</h3><p>Heterogeneity of findings is observed to depend on the size and location of the chromosomal alteration, and factors such as the concurrent development of diaphragmatic hernia are associated with a poorer prognosis and higher rates of mortality due to the degree of pulmonary hypoplasia.</p></div>","PeriodicalId":41294,"journal":{"name":"Clinica e Investigacion en Ginecologia y Obstetricia","volume":"51 4","pages":"Article 100968"},"PeriodicalIF":0.1,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141439280","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Clinica e Investigacion en Ginecologia y Obstetricia
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1